LSC Worldwide Issued Patents Covering Hydroxysomes‚Ñ¢, Dermal Delivery and Anti-Microbial Technologies

In the US, LSC technologies were initially included in one primary patent application filed with the US Patent & Trademark Office (PTO) on June 13, 1995. This application was later restricted to several separate inventions. Therefore the main body (specifications) of all of LSC's initial patent applications in the US is the same and the patents differ in their composition and method claims. LSC currently has 13 issued worldwide patents.

1. US Patent #6,096,324, issued August 1, 2000 
2. US Patent #6,099,849, issued August 8, 2000 
3. US Patent #6,120,782, issued September 19, 2000 
4. Commonwealth of Australia Patent #724,311, issued January 11, 2001 
5. Commonwealth of New Zealand Patent #311,461 issued April 4, 2002 
6. US Patent #6,579,516 B1, issued June 17, 2003 
7. Commonwealth of New Zealand Patent #513032 issued July 7, 2003 
8. Chinese Patent #ZL96190908.0, issued June 2, 2004
9. Commonwealth of Australia Patent #771272, issued July 8, 2004
10. Commonwealth of New Zealand Patent #523505 issued September 9, 2004
11. Canadian Patent #2,199,993, issued May 9, 2006
12. Commonwealth of Australia Patent #2004202660, issued March 6, 2008
13. European Patent No. 0776191B1, issued November 4, 2009